RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 137 filers reported holding RELAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $425,210 | -30.3% | 50,560 | +4.1% | 0.14% | -26.2% |
| Q2 2023 | $609,914 | +37.7% | 48,560 | +80.6% | 0.18% | +30.7% |
| Q1 2023 | $442,796 | +3.0% | 26,885 | -6.6% | 0.14% | -6.7% |
| Q4 2022 | $430,048 | -26.0% | 28,785 | +10.8% | 0.15% | -27.5% |
| Q3 2022 | $581,000 | +43.1% | 25,985 | +7.1% | 0.21% | +48.9% |
| Q2 2022 | $406,000 | -39.7% | 24,260 | +8.0% | 0.14% | -30.8% |
| Q1 2022 | $673,000 | -16.3% | 22,470 | -14.1% | 0.20% | -2.0% |
| Q4 2021 | $804,000 | -25.4% | 26,170 | -23.5% | 0.20% | -21.5% |
| Q3 2021 | $1,078,000 | -13.5% | 34,194 | +0.4% | 0.26% | -7.1% |
| Q2 2021 | $1,246,000 | +45.1% | 34,044 | +37.0% | 0.28% | +19.1% |
| Q1 2021 | $859,000 | +112.1% | 24,855 | +154.9% | 0.24% | +95.0% |
| Q4 2020 | $405,000 | – | 9,750 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,130,605 | $96,141,000 | 3.49% |
| Casdin Capital, LLC | 3,857,253 | $118,456,000 | 3.34% |
| Grace Capital | 183,112 | $5,623,000 | 3.34% |
| Boxer Capital, LLC | 2,669,132 | $81,969,000 | 3.18% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $856,961,000 | 2.50% |
| Integral Health Asset Management, LLC | 225,000 | $6,910,000 | 1.91% |
| Fernwood Investment Management, LLC | 185,063 | $5,683,000 | 1.86% |
| EcoR1 Capital, LLC | 1,779,084 | $54,636,000 | 1.74% |
| HARVARD MANAGEMENT CO INC | 541,124 | $16,618,000 | 1.56% |
| Bellevue Group AG | 4,105,962 | $126,094,000 | 1.30% |